The adjunct analgesic effect of metoclopramide for the intraoperative caesarean section patients by combined spinal epidural anesthesia (CSEA).

The adjunct analgesic effect of metoclopramide for the intraoperative caesarean section patients by combined spinal epidural anesthesia (CSEA). - The adjunct analgesic effect of metoclopramide for the intraoperative caesarean section patients by combined spinal epidural anesthesia (CSEA).

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010456

Enrollment

Registered

2013-04-10

Start date

2013-03-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women being to undergo elective caesarean section by combined spinal epidural anesthesia.

Interventions

Immediately after fetus delivery, we give normal saline (2ml) intravenously. Immediately after fetus delivery, we give metoclopramide (10mg/2ml) intravenously.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: ASA physical status 1 or 2, women being to undergo elective caesarean section by combined spinal epidural anesthesia.

Exclusion criteria

Exclusion criteria: Asthma. Hyper obesity (BMI over 35). ASA physical status 3 or higher. Other additional operations except tubal ligation. Operation more than 2 hours. Using a sadative agent or an additional analgesic agent before appearance of pain. Using metoclopramide before appearance of pain in normal saline group.

Design outcomes

Primary

Measure	Time frame
The presence or absence of pain in intraoperative patients. In the case of pain, the time from starting spinal anesthesia to appearance of the pain, degree of the pain (Numeric Rating Scale: 0~10), anesthetic level checked by using ice.	—

Countries

Japan

Contacts

Public ContactOtoya Yoshimoto

Kagoshima city hospital Department of anesthesiology

oyoshi-kago@umin.org099-224-2101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026